About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Comparative Study Between Rezum and Tamsulosin | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT07169773

Comparative Study Between Rezum and Tamsulosin

the investigators aimed to compare the efficacy and safety of Rezūm therapy for the management of benign prostatic hyperplasia (BPH) with Tamsulosin.

Lead sponsor: khaled Abdelsattar Gad Ibrahim•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

khaled Abdelsattar Gad Ibrahim

So far, data from available studies point towards good clinical outcomes with a short-term risk of self-limiting minor complications. Its application has demonstrated clinical effectiveness and possesses specific benefits that distinguish it among other treatments. It is applicable to outpatient setting, is effective in preserving sexual function and is versatile in its ability to treat a variety of prostate gland morphology.

Age

50 - 80 years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•1. with prostate volumes of 30- 80 mL,
•2. mild to mod LUTS
•3. (maximum urinary flow rate \[Q max\] of \<15 mL/s
•4. International Prostate Symptom Score \[IPSS\] of \>13)
•5. PVR urine \< 250 ml

Exclusion Criteria

•1. prostate cancer,
•2. neurogenic bladder
•3. urethral stricture,
•4. urinary bladder stone
•5. previous prostatic surgery

Related studies

BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY

NCT05443451 · Prostate Hyperplasia

Prostate Metabolism, Cancer Risk and Gut Microbiota

NCT06116851 · Prostate Cancer, Prostate Hyperplasia

Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH

NCT05440981 · Prostate Hyperplasia

COMPLETEDPhase 4

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

NCT01747577 · Overactive Bladder, Benign Prostate Hyperplasia, and more

Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia

NCT06520267 · Bacteriuria in Symptomatic Benign Prostate Hyperplasia, Antibiotic Susceptibility in Symptomatic Benign Prostate Hyperplasia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 12, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment94

Start dateMay 2022

Last updatedSep 12, 2025

Condition

Prostate Hyperplasia

Locations shown

The Armed Forces College of Medicine (AFCM

Cairo, Nozha

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 12, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions